Position in NAMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$674,207
-$44,673 QoQ
Shares Held
19,894
-11.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#120
of 197 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Derivatives in NAMS
reported options exposure · as of Jun 30, 2026CallValue
$671,022
CallShares
19,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tidal Investments LLC holds $326,523,942 across 90 Biotechnology names. NAMS ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,685 | $47,529,610 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
43,896 | $27,370,911 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
109,096 | $20,431,498 | |
| 4 | EXEL |
Exelixis, Inc.
|
375,316 | $20,420,943 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
190,305 | $14,895,171 | |
| 6 | INCY |
Incyte Corp
|
102,834 | $11,657,262 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,541 | $10,096,847 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
241,565 | $9,348,565 |
All Filings in NAMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $674,207 | 19,894 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $671,022 | 19,800 | Call | Defined | 2026-08-13 | |
| 2026-03-31 | $718,880 | 22,458 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $717,024 | 22,400 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $84,192 | 2,400 | Call | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||